Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2387201
Max Phase: Preclinical
Molecular Formula: C55H69N9O19
Molecular Weight: 1160.20
Molecule Type: Unknown
Associated Items:
ID: ALA2387201
Max Phase: Preclinical
Molecular Formula: C55H69N9O19
Molecular Weight: 1160.20
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)CCN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1
Standard InChI: InChI=1S/C55H69N9O19/c1-3-4-5-20-82-33-16-12-28(13-17-33)40-23-34(62-83-40)27-6-8-30(9-7-27)48(74)57-35-22-39(70)51(77)61-53(79)45-37(68)18-19-63(45)55(81)43(38(69)24-41(56)71)59-52(78)44(47(73)46(72)29-10-14-31(66)15-11-29)60-50(76)36-21-32(67)25-64(36)54(80)42(26(2)65)58-49(35)75/h6-17,23,26,32,35-39,42-47,51,65-70,72-73,77H,3-5,18-22,24-25H2,1-2H3,(H2,56,71)(H,57,74)(H,58,75)(H,59,78)(H,60,76)(H,61,79)/t26-,32-,35+,36+,37+,38-,39-,42+,43+,44+,45+,46+,47+,51-/m1/s1
Standard InChI Key: BPZOKZNEIMNZDY-JLLNUNJDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1160.20 | Molecular Weight (Monoisotopic): 1159.4710 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Singh SB, Herath K, Kahn JN, Mann P, Abruzzo G, Motyl M.. (2013) Synthesis and antifungal evaluation of pentyloxyl-diphenylisoxazoloyl pneumocandins and echinocandins., 23 (11): [PMID:23623416] [10.1016/j.bmcl.2013.03.115] |
Source(1):